High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy.
J Clin Med
; 13(16)2024 Aug 13.
Article
in En
| MEDLINE
| ID: mdl-39200906
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Med
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland